Citichem India (BSE 544324)₹16.00−3.03%Trading - Chemicals
In the Mar 2026 quarter (standalone), Citichem India reported sales of ₹4.67 Cr, down 91.1% from Mar 2025, and net profit of ₹0.31 Cr, down 71.8% year on year. For the year to Mar 2026, sales were ₹14.74 Cr and net profit ₹0.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 1.66 | 52.50 | 10.07 | 4.67 |
| Expenses | 1.51 | 51.42 | 9.60 | 3.91 |
| Operating Profit | 0.18 | 1.46 | 0.54 | 0.79 |
| OPM % | 10.2% | 2.8% | 5.3% | 16.7% |
| Other Income | 0.00 | 0.37 | 0.66 | 0.04 |
| Interest | 0.00 | 0.32 | 0.27 | 0.33 |
| Depreciation | 0.00 | 0.00 | 0.02 | 0.02 |
| Profit before tax | 0.15 | 1.49 | 0.90 | 0.45 |
| Tax % | 25.0% | 26.0% | 25.3% | 30.5% |
| Net Profit | 0.11 | 1.10 | 0.67 | 0.31 |
| EPS (Rs) | 0.23 | 1.62 | 0.99 | 0.46 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 127 | 179 | 84.89 | 20.89 | 19.55 | 54.17 | 14.74 |
| Expenses | 127 | 180 | 85.10 | 20.41 | 17.86 | 52.92 | 13.51 |
| Operating Profit | 0.29 | 0.22 | 0.39 | 0.59 | 1.81 | 1.63 | 1.32 |
| OPM % | 0.2% | 0.1% | 0.5% | 2.8% | 9.2% | 3.0% | 8.9% |
| Other Income | 0.02 | 0.10 | 0.05 | 0.00 | 0.00 | 0.37 | 0.71 |
| Interest | 0.02 | 0.00 | 0.11 | 0.07 | 0.08 | 0.32 | 0.59 |
| Depreciation | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.05 |
| Profit before tax | 0.26 | 0.29 | 0.31 | 0.50 | 1.70 | 1.65 | 1.36 |
| Tax % | 25.9% | 26.7% | 28.2% | 29.4% | 18.7% | 25.9% | 27.0% |
| Net Profit | 0.19 | 0.21 | 0.23 | 0.35 | 1.38 | 1.22 | 0.99 |
| EPS (Rs) | — | — | 0.47 | 0.71 | 2.77 | 1.80 | 1.46 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.08 | 0.08 | 5.01 | 5.02 | 5.02 | 6.82 | 6.82 |
| Reserves | 0.32 | 0.54 | 0.78 | 1.14 | 2.53 | 13.34 | 14.35 |
| Borrowings | 0.38 | 0.00 | 1.12 | 1.11 | 1.09 | 5.41 | 7.76 |
| Other Liabilities | 32.05 | 72.83 | 84.79 | 72.73 | 60.91 | 44.60 | 26.09 |
| Total Liabilities | 32.83 | 73.45 | 91.70 | 80.00 | 69.55 | 70.17 | 55.02 |
| Fixed Assets | 0.09 | 0.10 | 0.09 | 0.11 | 0.11 | 0.07 | 0.94 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 32.74 | 73.35 | 91.61 | 79.89 | 69.44 | 70.10 | 54.08 |
| Inventories | 26.02 | 34.50 | 41.18 | 44.63 | 37.36 | 6.17 | 6.63 |
| Trade receivables | 1.92 | 33.51 | 46.31 | 34.10 | 30.53 | 50.96 | 37.12 |
| Cash & equivalents | 0.08 | 0.07 | 0.04 | 0.20 | 0.61 | 4.48 | 0.67 |
| Total Assets | 32.83 | 73.45 | 91.70 | 80.00 | 69.55 | 70.17 | 55.02 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.38 | 0.39 | −5.96 | 0.29 | 0.50 | −11.54 | −5.20 |
| Cash from investing activity | −0.02 | −0.03 | −0.02 | −0.05 | 0.00 | 0.04 | −0.37 |
| Cash from financing activity | −0.43 | −0.38 | 5.95 | −0.08 | −0.09 | 15.36 | 1.76 |
| Net cash flow | −0.06 | −0.01 | −0.02 | 0.16 | 0.40 | 3.85 | −3.79 |
| Capex | 0.00 | 0.02 | 0.00 | 0.03 | 0.00 | 0.00 | 0.91 |
| Free cash flow | 0.35 | 0.34 | −5.95 | 0.23 | 0.48 | −11.47 | −6.10 |
| CFO / OP % | 174.9% | 133.0% | −1,566.1% | 47.9% | 27.9% | −710.1% | −390.1% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 7 | 69 | 200 | 597 | 570 | 344 | 919 |
| Inventory days | 77 | 72 | 181 | 858 | 850 | 47 | 232 |
| Days payable | 93 | 149 | 369 | 1,379 | 1,349 | 316 | 855 |
| Cash conversion cycle | −11 | −9 | 11 | 75 | 71 | 73 | 295 |
| Working capital days | 1 | 0 | 28 | 117 | 144 | 57 | 288 |
| ROCE % | — | 44.5% | 11.3% | 8.1% | 22.5% | 11.6% | 7.2% |
For the Mar 2026 quarter, Citichem India reported sales of ₹4.67 Cr, down 91.1% year on year and net profit of ₹0.31 Cr, down 71.8% year on year. The operating margin was 16.7%.
Citichem India's sales for the year to Mar 2026 were ₹14.74 Cr.
Net profit for the year to Mar 2026 was ₹0.99 Cr. Earnings per share over the same trailing period were ₹1.46.
Citichem India reported borrowings of ₹7.76 Cr at Mar 2026, against cash and equivalents of ₹0.67 Cr.
Cash from operations was −₹5.20 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹6.10 Cr.